Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4299240
Max Phase: Preclinical
Molecular Formula: C67H110N16O10
Molecular Weight: 1299.72
Molecule Type: Small molecule
Associated Items:
ID: ALA4299240
Max Phase: Preclinical
Molecular Formula: C67H110N16O10
Molecular Weight: 1299.72
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)NC(C)(C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N(C)[C@H](CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C67H110N16O10/c1-8-9-10-11-12-13-14-15-16-17-18-19-26-37-56(85)80-67(4,5)64(93)79-50(42-46-30-22-20-23-31-46)59(88)77-49(41-45(2)3)58(87)78-51(43-47-32-24-21-25-33-47)62(91)81(6)53(35-28-39-75-66(72)73)63(92)83-40-29-36-52(83)60(89)76-48(34-27-38-74-65(70)71)61(90)82(7)54(57(69)86)44-55(68)84/h20-25,30-33,45,48-54H,8-19,26-29,34-44H2,1-7H3,(H2,68,84)(H2,69,86)(H,76,89)(H,77,88)(H,78,87)(H,79,93)(H,80,85)(H4,70,71,74)(H4,72,73,75)/t48-,49-,50-,51+,52+,53+,54-/m1/s1
Standard InChI Key: IVESVAAXJYKNDI-VQQAPNMWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1299.72 | Molecular Weight (Monoisotopic): 1298.8591 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Micewicz ED, Bahattab OS, Willars GB, Waring AJ, Navab M, Whitelegge JP, McBride WH, Ruchala P.. (2015) Small lipidated anti-obesity compounds derived from neuromedin U., 101 [PMID:26204509] [10.1016/j.ejmech.2015.07.020] |
Source(1):